This page shows the latest Immunicom news and features for those working in and with pharma, biotech and healthcare.
The process is based on a proprietary recombinant protein initially developed at University of Stuttgart from which Immunicom has licensed the worldwide exclusive rights. ... Immunicom's therapeutic approach is still very much in its early stages, the
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...